Covered recipient · General Payments record
LILY L MOORE
Podiatric Medicine & Surgery Service Providers Podiatrist
General Payments · PY2018–2024
$4,330.31
- Reported across 135 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.59 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $66.57 | 3 |
| Medtronic, Inc. | $43.13 | 2 |
| ConvaTec Inc. | $35.00 | 1 |
| Kerecis Limited | $34.15 | 2 |
| Stryker Corporation | $31.60 | 2 |
| Smith & Nephew, Inc. | $29.51 | 2 |
| ORGANOGENESIS INC. | $24.52 | 1 |
| Amgen Inc. | $22.99 | 1 |
| Nevro Corp. | $22.80 | 1 |
| Solventum Corporation | $16.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.99 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111655463 | CMS |
| Averitas Pharma Inc. | $24.47 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133437890 | CMS |
| Averitas Pharma Inc. | $20.21 | 10/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133437894 | CMS |
| Averitas Pharma Inc. | $21.89 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133437898 | CMS |
| ConvaTec Inc. | $35.00 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151380559 | CMS |
| Kerecis Limited | $21.68 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120096453 | CMS |
| Kerecis Limited | $12.47 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120103678 | CMS |
| Medtronic, Inc. | $21.46 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119400958 | CMS |
| Medtronic, Inc. | $21.67 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119400960 | CMS |
| Nevro Corp. | $22.80 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130733739 | CMS |
| Organogenesis Inc. | $24.52 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145439739 | CMS |
| Smith+Nephew, Inc. | $16.22 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531392 | CMS |
| Smith+Nephew, Inc. | $13.29 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531390 | CMS |
| Solventum Corporation | $16.32 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144059288 | CMS |
| Stryker Corporation | $17.24 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119921872 | CMS |
| Stryker Corporation | $14.36 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119921874 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.